Long-term follow-up of patients developing gastric mucosal lesions after initiating the potassium-competitive acid blocker vonoprazan

키워드

참고문헌 (10)

1. -N-methylmethanamine fumarate(TAK-438)as a potassium-competitive acid blocker(P-CAB), "J Med Chem", 2012, 4446~4456
2. Parsons ME, "Novel approaches to the pharmacological blockade of gastric acid secretion", Expert Opin Investig Drugs, 14, pp.411~421 (2005)
3. Matsukawa J, "Radiographic localization study of a novel potassium-competitive acid blocker, vonoprazan, in the rat gastric mucosa", Dig Dis Sci, 61, pp.1888~1894 (2016)
4. Miyamoto S, "Parietal cell protrusions and dilated oxyntic glands from use of vonoprazan", Am J Gastroenterol, 112, pp.1899~1901 (2017)
5. Kubo K, "Vonoprazan-associated gastric mucosal redness : a report of four cases", Intern Med, 59, pp.507~511 (2020)
6. Kubo K, "Vonoprazan-associated gastric mucosal redness in non-Helicobacter pylori-infected and Helicobacter pylori-eradicated stomach", Case Rep Gastroenterol, 15, pp.751~758 (2021)
7. Nishiyama N, "White spot, a novel endoscopic finding, may be associated with acid-suppressing agents and hypergastrinemia", J Clin Med, 10, pp.2625~ (2021)
8. Yoshizaki T, "Propensity score matching analysis : incidence and risk factors for"stardust"gastric mucosa, a novel gastric finding potentially induced by vonoprazan", Aliment Pharmacol Ther, 53, pp.94~102 (2021)
9. Iwamuro M, "Gastric polyps' regression after potassium-competitive acid blocker cessation", J Gen Fam Med, 23, pp.358~359 (2022)
10. Goto C, "Long-term vonoprazan administration causes gastric fundic gland-type hyperplastic polyps and chronic bleeding", Clin J Gastroenterol, 16, pp.159~163 (2023)

관련 논문AI추천